Companies / Texas / Salarius Pharmaceuticals

· rebuilt nightly from public records

Signal Sheet

Selling to Salarius Pharmaceuticals? Who to reach and why now

Salarius Pharmaceuticals is a publicly listed pharmaceutical preparations company in Houston, Texas. It raised $10M in Dec 2024 and its filings name 8 officers. Everything below links to the record it came from.

Listed company · Pharmaceutical Preparations · Texas

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerMark J. RosenblumSEC filing, Dec 2024Named officer in the filing; part of the buying group
Chief Technology OfficerDavid J. ArthurSEC filing, Dec 2024Technology and tooling decisions
Chief Technology OfficerWilliam McVicarSEC filing, Dec 2024Technology and tooling decisions
Chief Technology OfficerJonathan LieberSEC filing, Dec 2024Technology and tooling decisions
Chief Technology OfficerTess BurlesonSEC filing, Dec 2024Technology and tooling decisions
Chief Technology OfficerArnold C. HanishSEC filing, Dec 2024Technology and tooling decisions
Chief Technology OfficerPaul LammersSEC filing, Dec 2024Technology and tooling decisions
Chief Technology OfficerBruce J. McCreedySEC filing, Dec 2024Technology and tooling decisions
For sellersWhy Salarius Pharmaceuticals is worth a call this quarterBuy Window: open · major agreement Sep 2026
Oct 2026Oct 2026

Capital

Filed to go public

Capital
Sep 2026Sep 2026

Corporate event

Signed a material agreement

Corporate event
8officers

Named in filings

Each with a title and the filing that names them, so the first call goes to the right desk.

People
Track Salarius Pharmaceuticals with a free trial →Get the next signal the day it is filed or posted.
Email me the next Salarius Pharmaceuticals signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Oct 7, 2026Filed to go publicCapitalSEC filing
Sep 22, 2026Signed a material agreementCorporate eventSEC filing
Dec 27, 2024Raised $10M in equity from 1 investorsCapitalSEC filing

Reach Salarius Pharmaceuticals with emails that land

Lakewave finds the right people at Salarius Pharmaceuticals, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on Salarius Pharmaceuticals with a free trial →

About Salarius Pharmaceuticals

HeadquartersHouston, Texas, per the filing address
Industry groupPharmaceutical Preparations
OwnershipListed company
Raise history$10M (Dec 2024)
Lakewave Rising34 · 2 kinds of evidence · rank in Texas after sign-up

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Actuate Therapeutics · 50Tivic Health Systems · 35Cerenome · 33Sensei Biotherapeutics · 17CNS Pharmaceuticals · 9See all 5 with a free trial →

Questions people ask

Did Salarius Pharmaceuticals raise funding in 2024?

Yes. Salarius Pharmaceuticals reported a $10M equity raise to the SEC on Dec 27, 2024 with 1 investors.

Who runs Salarius Pharmaceuticals?

The company's SEC filing, Dec 2024 names Mark J. Rosenblum (Executive Officer) among its officers.

Where is Salarius Pharmaceuticals headquartered?

Houston, Texas, per the address on its SEC filing.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.